These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20874422)

  • 21. Characterization of nanomaterials for toxicity assessment.
    Sayes CM; Warheit DB
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(6):660-70. PubMed ID: 20049823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptations of the in vitro MN assay for the genotoxicity assessment of nanomaterials.
    Gonzalez L; Sanderson BJ; Kirsch-Volders M
    Mutagenesis; 2011 Jan; 26(1):185-91. PubMed ID: 21164201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the Ames test provide an insight into nano-object mutagenicity? Investigating the interaction between nano-objects and bacteria.
    Clift MJ; Raemy DO; Endes C; Ali Z; Lehmann AD; Brandenberger C; Petri-Fink A; Wick P; Parak WJ; Gehr P; Schins RP; Rothen-Rutishauser B
    Nanotoxicology; 2013 Dec; 7(8):1373-85. PubMed ID: 23078217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The status of in vitro toxicity studies in the risk assessment of nanomaterials.
    Park MV; Lankveld DP; van Loveren H; de Jong WH
    Nanomedicine (Lond); 2009 Aug; 4(6):669-85. PubMed ID: 19663595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Culture medium-associated physicochemical insights on the cytotoxicity of carbon nanomaterials.
    Kong H; Wang L; Zhu Y; Huang Q; Fan C
    Chem Res Toxicol; 2015 Mar; 28(3):290-5. PubMed ID: 25580995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies in case of positive in vivo results in genotoxicity testing.
    Thybaud V; Macgregor JT; Müller L; Crebelli R; Dearfield K; Douglas G; Farmer PB; Gocke E; Hayashi M; Lovell DP; Lutz WK; Marzin D; Moore M; Nohmi T; Phillips DH; Van Benthem J
    Mutat Res; 2011 Aug; 723(2):121-8. PubMed ID: 20854927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutagenicity as a sequela of DNA-modifying potential of water pollutants].
    Zahn RK
    Schriftenr Ver Wasser Boden Lufthyg; 1992; 89():733-43. PubMed ID: 1307836
    [No Abstract]   [Full Text] [Related]  

  • 28. Strategies in genotoxicity testing.
    Vondráček J
    Food Chem Toxicol; 2017 Aug; 106(Pt B):573. PubMed ID: 27470614
    [No Abstract]   [Full Text] [Related]  

  • 29. Attainment of minimal biological variability and measurements of genotoxicity: production of homozygous diploid zebra fish.
    Streisinger G
    Natl Cancer Inst Monogr; 1984 May; 65():53-8. PubMed ID: 6462198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic potential of materials at the nanolevel.
    Nel A; Xia T; Mädler L; Li N
    Science; 2006 Feb; 311(5761):622-7. PubMed ID: 16456071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective analysis of the mutagenicity/genotoxicity data of the cosmetic ingredients present on the Annexes of the Cosmetic EU legislation (2000-12).
    Ates G; Doktorova TY; Pauwels M; Rogiers V
    Mutagenesis; 2014 Mar; 29(2):115-21. PubMed ID: 24435663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical factors to be considered when testing nanomaterials for genotoxicity with the comet assay.
    Huk A; Collins AR; El Yamani N; Porredon C; Azqueta A; de Lapuente J; Dusinska M
    Mutagenesis; 2015 Jan; 30(1):85-8. PubMed ID: 25527731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvements in the reliability of in vitro genotoxicity testing.
    Kirkland D
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1513-20. PubMed ID: 22098140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granular biodurable nanomaterials: No convincing evidence for systemic toxicity.
    Moreno-Horn M; Gebel T
    Crit Rev Toxicol; 2014 Nov; 44(10):849-75. PubMed ID: 25257841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genotoxicity evaluation of nanoparticles].
    Durnev AD
    Gig Sanit; 2014; (2):76-83. PubMed ID: 25051747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The International Workshops on Genotoxicity Testing (IWGT): history and achievements.
    Kirkland DJ; Hayashi M; Jacobson-Kram D; Kasper P; MacGregor JT; Müller L; Uno Y
    Mutat Res; 2007 Feb; 627(1):1-4. PubMed ID: 17127092
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials.
    Maser E; Schulz M; Sauer UG; Wiemann M; Ma-Hock L; Wohlleben W; Hartwig A; Landsiedel R
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Dec; 794():57-74. PubMed ID: 26653985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.